{"transactions":[{"id":2222047,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T06:39:30.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in twelve (12) equal monthly installments commencing on July 23, 2022, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":12500,"derivative":{"exercise_price":1.6,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-22-039082","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671818/000120919122039082/doc4.xml","form_type":"4"}},{"id":2502606,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:10:52.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":9.22,"expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-21-065715","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065715/doc4.xml","form_type":"4"}},{"id":2502605,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:10:52.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":11.88,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-21-065715","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065715/doc4.xml","form_type":"4"}},{"id":2502604,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:10:52.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":11.74,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-065715","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065715/doc4.xml","form_type":"4"}},{"id":2502603,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:10:52.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":28.14,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-065715","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065715/doc4.xml","form_type":"4"}},{"id":2502602,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:10:52.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":20.16,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-065715","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065715/doc4.xml","form_type":"4"}},{"id":2502601,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:10:52.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":13.83,"expiration_date":"2026-06-09","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-065715","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065715/doc4.xml","form_type":"4"}},{"id":2502600,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:10:52.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":9000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":21.85,"expiration_date":"2025-06-16","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-21-065715","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065715/doc4.xml","form_type":"4"}},{"id":2502599,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:10:52.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":18000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":25.38,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-21-065715","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065715/doc4.xml","form_type":"4"}},{"id":2502598,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T10:10:52.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":9000,"price":8.5,"value":76500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc. (\"Issuer\"), Pacira BioSciences, Inc. and Oyster Acquisition Company Inc. (\"Purchaser\") (\"Merger Agreement\"), on November 19, 2021, Purchaser merged with and into Issuer, with Issuer continuing as the surviving corporation (\"Merger\"). At the effective time of the Merger, each share of Issuer's common stock was cancelled in exchange for (i) $8.50 per share in cash (\"Cash Amount\"), plus (ii) one non-transferable contractual contingent value right per share, which represent the right to receive one or more contingent payments of up to $8.00 per share in the aggregate, in cash, upon the achievement of specified milestones on or prior to December 31, 2030 (\"CVR Payments\"). Pursuant to the Merger Agreement, these shares were tendered and disposed of at the offer acceptance time in exchange for the right to receive (i) the Cash Amount, plus (ii) any CVR Payments."},{"field":"shares","element":"transactionShares","label":"F2","text":"At the effective time of the Merger, each outstanding restricted stock unit award (\"RSU\") was accelerated and became fully vested and was cancelled and converted into the right to receive (i) $8.50 per share of Issuer common stock issuable in settlement of such RSU in cash, net of any withholding taxes required to be deducted and withheld by applicable law, plus (ii) any potential CVR Payments."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-065715","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065715/doc4.xml","form_type":"4"}},{"id":2653293,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-06-28T18:38:11.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":7000,"derivative":{"exercise_price":9.22,"expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-21-043554","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121043554/doc4.xml","form_type":"4"}},{"id":2653292,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T18:38:11.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-21-043554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121043554/doc4.xml","form_type":"4"}},{"id":2663834,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T17:54:49.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in 12 equal monthly installments commencing on July 16, 2021, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":12500,"derivative":{"exercise_price":16.55,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-041613","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671818/000120919121041613/doc4.xml","form_type":"4"}},{"id":2663830,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T17:45:45.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The original Form 4 filed on December 16, 2020 inadvertently listed the incorrect vesting terms.  The correct vesting is: one thirty-sixth (1/36th) of the shares subject to the option shall vest each month commencing on January 11, 2021, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":25000,"derivative":{"exercise_price":26,"expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-041603","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671818/000120919121041603/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-16"}},{"id":2942616,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-16T17:15:02.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option shall vest on December 11, 2021, and one twenty-fourth (1/24th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":25000,"derivative":{"exercise_price":26,"expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-063838","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671818/000120919120063838/doc4.xml","form_type":"4"}},{"id":3001158,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-10-23T17:34:51.000Z","date":"2020-10-23","kind":"disposition_to_issuer","acquired":false,"shares":3718,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"In connection with the consummation of the Merger, at the Effective Time, each restricted stock unit to acquire shares of Common Stock (\"Restricted Stock Unit\") that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash equal to (A) the Offer Price, multiplied by (B) the total number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the consummation of the Merger, at the Effective Time, each restricted stock unit to acquire shares of Common Stock (\"Restricted Stock Unit\") that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash equal to (A) the Offer Price, multiplied by (B) the total number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In connection with the consummation of the Merger, at the Effective Time, each restricted stock unit to acquire shares of Common Stock (\"Restricted Stock Unit\") that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash equal to (A) the Offer Price, multiplied by (B) the total number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"In connection with the consummation of the Merger, at the Effective Time, each restricted stock unit to acquire shares of Common Stock (\"Restricted Stock Unit\") that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash equal to (A) the Offer Price, multiplied by (B) the total number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3718},"source":{"system":"sec-edgar","filing":"0001104659-20-117803","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920117803/a4.xml","form_type":"4"}},{"id":3001157,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-23T17:34:51.000Z","date":"2020-10-23","kind":"disposition_to_issuer","acquired":false,"shares":155286,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":155286},"source":{"system":"sec-edgar","filing":"0001104659-20-117803","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920117803/a4.xml","form_type":"4"}},{"id":3001156,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-23T17:34:51.000Z","date":"2020-10-23","kind":"disposition_to_issuer","acquired":false,"shares":13516,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.01 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was automatically cancelled and converted into the right to receive $88.00 in cash (the \"Offer Price\"), without interest and subject to required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.01 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was automatically cancelled and converted into the right to receive $88.00 in cash (the \"Offer Price\"), without interest and subject to required withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-117803","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920117803/a4.xml","form_type":"4"}},{"id":3103708,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-22T17:19:37.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":6540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2020 annual meeting of stockholders, which occurred on June 18, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":6540,"derivative":{"exercise_price":33.62,"exercise_date":"2021-06-18","expiration_date":"2030-06-18","underlying":"Common Stock, par value $0.01 per share","underlying_shares":6540},"source":{"system":"sec-edgar","filing":"0001104659-20-075693","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920075693/a4.xml","form_type":"4"}},{"id":3103707,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value per share","published_at":"2020-06-22T17:19:37.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":3718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2020 annual meeting of stockholders, which occurred on June 18, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":17234,"source":{"system":"sec-edgar","filing":"0001104659-20-075693","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920075693/a4.xml","form_type":"4"}},{"id":3111652,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-06-12T16:11:35.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":7000,"derivative":{"exercise_price":11.88,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-20-036247","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919120036247/doc4.xml","form_type":"4"}},{"id":3111651,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T16:11:35.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan."}],"balance_after":4500,"source":{"system":"sec-edgar","filing":"0001209191-20-036247","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919120036247/doc4.xml","form_type":"4"}},{"id":3481220,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-06-21T16:04:34.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":12500,"derivative":{"exercise_price":11.74,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-19-038454","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919119038454/doc4.xml","form_type":"4"}},{"id":3495038,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-11T16:29:30.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":17077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2019 annual meeting of stockholders, which occurred on June 7, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":17077,"derivative":{"exercise_price":12.93,"exercise_date":"2020-06-07","expiration_date":"2026-06-07","underlying":"Common Stock, par value $0.01 per share","underlying_shares":17077},"source":{"system":"sec-edgar","filing":"0001104659-19-034787","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465919034787/a4.xml","form_type":"4"}},{"id":3495037,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value per share","published_at":"2019-06-11T16:29:30.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":9667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2019 annual meeting of stockholders, which occurred on June 7, 2019."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":13516,"source":{"system":"sec-edgar","filing":"0001104659-19-034787","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465919034787/a4.xml","form_type":"4"}},{"id":3495450,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-06-10T16:03:57.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"Stock Option\").  100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":20100,"derivative":{"exercise_price":4.23,"exercise_date":"2020-06-06","expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001562180-19-003433","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303416/000156218019003433/primarydocument.xml","form_type":"4"}},{"id":3495449,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-10T16:03:57.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":13700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"RSUs\").  100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":13700,"source":{"system":"sec-edgar","filing":"0001562180-19-003433","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303416/000156218019003433/primarydocument.xml","form_type":"4"}},{"id":3603379,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-03-11T16:48:04.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":22854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted stock options pursuant to the Issuer's 2014 Long-Term Incentive Plan. The stock options vest in full upon the Issuer's receipt of approval from the U.S. Food and Drug Administration for the Issuer's Biologics License Application for sacituzumab govitecan for the treatment of patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease under the Prescription Drug User Fee Act."}],"balance_after":22854,"derivative":{"exercise_price":16.35,"expiration_date":"2026-03-08","underlying":"Common Stock, par value $0.01 per share","underlying_shares":22854},"source":{"system":"sec-edgar","filing":"0001104659-19-013869","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465919013869/a4.xml","form_type":"4"}},{"id":3603378,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-03-11T16:48:04.000Z","date":"2019-03-05","kind":"grant","acquired":true,"shares":79818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted stock options pursuant to the Issuer's 2014 Long-Term Incentive Plan. The stock options vest in full upon the Issuer's receipt of approval from the U.S. Food and Drug Administration for the Issuer's Biologics License Application for sacituzumab govitecan for the treatment of patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease under the Prescription Drug User Fee Act."}],"balance_after":79818,"derivative":{"exercise_price":16.96,"expiration_date":"2026-03-05","underlying":"Common Stock, par value $0.01 per share","underlying_shares":79818},"source":{"system":"sec-edgar","filing":"0001104659-19-013869","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465919013869/a4.xml","form_type":"4"}},{"id":3813724,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-09-18T14:59:09.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":6497,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2018 annual meeting of stockholders, which occurred on April 2, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":6497,"derivative":{"exercise_price":14.29,"exercise_date":"2019-04-02","expiration_date":"2025-04-02","underlying":"Common Stock, par value $0.01 per share","underlying_shares":6497},"source":{"system":"sec-edgar","filing":"0001171843-18-006604","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000117184318006604/ownership.xml","form_type":"4"}},{"id":3813723,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value per share","published_at":"2018-09-18T14:59:09.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":3849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2018 annual meeting of stockholders, which occurred on April 2, 2018."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":3849,"source":{"system":"sec-edgar","filing":"0001171843-18-006604","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000117184318006604/ownership.xml","form_type":"4"}},{"id":3886002,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-06-21T16:10:41.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":12500,"derivative":{"exercise_price":28.14,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-18-038931","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919118038931/doc4.xml","form_type":"4"}},{"id":3892212,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2018-06-15T08:16:33.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an option to purchase shares of Akebia Therapeutics, Inc.'s (the \"Company's\") common stock granted by the Company pursuant to the Company's 2014 Incentive Plan (the \"Stock Option\").  100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company."}],"balance_after":12500,"derivative":{"exercise_price":11.14,"exercise_date":"2019-06-14","expiration_date":"2028-06-14","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001562180-18-003014","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303416/000156218018003014/primarydocument.xml","form_type":"4"}},{"id":3898126,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-11T16:31:49.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":12700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on June 8, 2018 and the shares underlying this option will vest 100% at the earlier of (i) June 8, 2019 and (ii) the Issuer's next annual meeting of stockholders."}],"balance_after":12700,"derivative":{"exercise_price":2.5,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":12700},"source":{"system":"sec-edgar","filing":"0001171843-18-004579","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303416/000117184318004579/formfour.xml","form_type":"4"}},{"id":4178374,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-30T18:02:53.000Z","date":"2017-10-26","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option shall vest on October 26, 2018, subject to the Reporting Person providing continuous service to the Issuer on such date."}],"balance_after":15000,"derivative":{"exercise_price":1.32,"expiration_date":"2027-10-26","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-058361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303416/000120919117058361/doc4.xml","form_type":"4"}},{"id":4249997,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-27T09:36:10.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":12500,"derivative":{"exercise_price":20.16,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-17-046388","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919117046388/doc4.xml","form_type":"4"}},{"id":4262918,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-07-06T18:04:11.000Z","date":"2017-07-03","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22500,"derivative":{"exercise_price":9.02,"exercise_date":"2018-07-03","expiration_date":"2024-07-03","underlying":"Common Stock, par value $0.01 per share","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001104659-17-043899","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465917043899/a4.xml","form_type":"4"}},{"id":4275143,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-21T16:18:16.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":6666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on June 20, 2017 and the shares underlying this option will vest 100% at the earlier of (i) June 20, 2018 and (ii) the Issuer's next annual meeting of stockholders."}],"balance_after":6666,"derivative":{"exercise_price":1.3,"expiration_date":"2027-06-19","underlying":"Common Stock, $0.001 par value","underlying_shares":6666},"source":{"system":"sec-edgar","filing":"0001171843-17-003746","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303416/000117184317003746/formfour.xml","form_type":"4"}},{"id":4277153,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-06-19T16:05:16.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option shares vest on the first anniversary of the date of grant (the \"Vesting Date\"), provided that the Reporting Person remains in continuous service as a member of the Issuer's Board of Directors through the Vesting Date, and provided further that the options held by the Reporting Person shall be eligible for vesting acceleration upon a \"Change in Control\" as defined and provided for in the Issuer's Non-Employee Director Stock Option Award Agreement."}],"balance_after":12500,"derivative":{"exercise_price":14.37,"exercise_date":"2018-06-15","expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001562180-17-002294","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303416/000156218017002294/primarydocument.xml","form_type":"4"}},{"id":4511759,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2016-12-27T16:54:05.000Z","date":"2016-12-22","kind":"purchase","acquired":true,"shares":80500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person acquired a Senior Secured Note in the principal amount of $350,000 together with a Warrant to purchase 80,500 shares of the common stock of the Issuer in exchange for the Reporting Person's Unsecured Bridge Note in the principal amount of $350,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately exercisable."}],"balance_after":80500,"derivative":{"exercise_price":3,"expiration_date":"2021-12-22","underlying":"Common Stock","underlying_shares":80500},"source":{"system":"sec-edgar","filing":"0001209191-16-156824","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303416/000120919116156824/doc4.xml","form_type":"4"}},{"id":4538504,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2016-11-30T17:22:46.000Z","date":"2016-11-28","kind":"other","acquired":true,"shares":37315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Proximare Lifesciences Fund LLC, of which the reporting person is a member."},{"field":"shares","element":"transactionShares","label":"F1","text":"Pro rata distribution from Proximare Lifesciences Fund LLC, of which the reporting person is a member."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Pro rata distribution from Proximare Lifesciences Fund LLC, of which the reporting person is a member."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Pro rata distribution from Proximare Lifesciences Fund LLC, of which the reporting person is a member."}],"balance_after":37315,"derivative":{"exercise_price":0.01,"expiration_date":"2019-11-08","underlying":"Common Stock","underlying_shares":37315},"source":{"system":"sec-edgar","filing":"0001209191-16-152512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303416/000120919116152512/doc4.xml","form_type":"4"}},{"id":4538503,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-30T17:22:46.000Z","date":"2016-11-28","kind":"other","acquired":true,"shares":57408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Proximare Lifesciences Fund LLC, of which the reporting person is a member."},{"field":"shares","element":"transactionShares","label":"F1","text":"Pro rata distribution from Proximare Lifesciences Fund LLC, of which the reporting person is a member."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pro rata distribution from Proximare Lifesciences Fund LLC, of which the reporting person is a member."}],"balance_after":246342,"source":{"system":"sec-edgar","filing":"0001209191-16-152512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303416/000120919116152512/doc4.xml","form_type":"4"}},{"id":4557385,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-14T18:18:21.000Z","date":"2016-11-09","kind":"exercise","acquired":true,"shares":57971,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the right to receive, at settlement, one (1) share of the Issuer's common stock."}],"balance_after":188934,"source":{"system":"sec-edgar","filing":"0001214659-16-014638","document":"marketforms-36752.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303416/000121465916014638/marketforms-36752.xml","form_type":"4"}},{"id":4557384,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2016-11-14T18:18:21.000Z","date":"2016-11-09","kind":"exercise","acquired":false,"shares":57971,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's 2015 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the right to receive, at settlement, one (1) share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"The RSUs vest upon the first to occur of (x) a change of control as defined in the award agreement and (y) the expiration of the 6 month lock-up period following the Issuer's initial public offering (\"IPO\"), in each case subject to continued service through such event."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001214659-16-014638","document":"marketforms-36752.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303416/000121465916014638/marketforms-36752.xml","form_type":"4"}},{"id":251982,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2007-02-12T20:06:59.000Z","date":"2006-06-13","kind":"gift","acquired":false,"shares":1293,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Amy D. Canute Rev. Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Revocable Trust of which reporting person and his wife are trustee."}],"balance_after":18078,"source":{"system":"sec-edgar","filing":"0001209191-07-009372","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919107009372/doc5.xml","form_type":"5"}},{"id":252348,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2007-02-05T23:23:40.000Z","date":"2007-02-01","kind":"tax_withholding","acquired":false,"shares":3668,"price":54.12,"value":198512.16,"ownership":{"direct":true},"balance_after":25367,"source":{"system":"sec-edgar","filing":"0001209191-07-007667","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919107007667/doc4.xml","form_type":"4"}},{"id":252872,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2007-01-19T20:33:30.000Z","date":"2007-01-17","kind":"grant","acquired":true,"shares":17355,"price":52.86,"value":917385.3,"ownership":{"direct":true},"balance_after":29035,"source":{"system":"sec-edgar","filing":"0001209191-07-004338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919107004338/doc4.xml","form_type":"4"}},{"id":267399,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Employee stock option 2/06 (right to buy)","published_at":"2006-02-14T22:02:05.000Z","date":"2006-02-10","kind":"grant","acquired":true,"shares":39157,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39157,"derivative":{"exercise_price":56.18,"exercise_date":"2009-02-10","expiration_date":"2016-02-09","underlying":"Common Stock","underlying_shares":39157},"source":{"system":"sec-edgar","filing":"0001209191-06-010481","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919106010481/doc4.xml","form_type":"4"}},{"id":267429,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2006-02-14T17:07:43.000Z","date":"2005-08-29","kind":"gift","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Amy D. Canute Rev. Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Revocable Trust of which reporting person and his wife are trustee."}],"balance_after":19371,"source":{"system":"sec-edgar","filing":"0001209191-06-010178","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919106010178/doc5.xml","form_type":"5"}},{"id":267428,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2006-02-14T17:07:43.000Z","date":"2005-06-28","kind":"gift","acquired":false,"shares":6,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Amy D. Canute Rev. Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Revocable Trust of which reporting person and his wife are trustee."}],"balance_after":14480,"source":{"system":"sec-edgar","filing":"0001209191-06-010178","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919106010178/doc5.xml","form_type":"5"}},{"id":267427,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2006-02-14T17:07:43.000Z","date":"2005-06-23","kind":"gift","acquired":false,"shares":1324,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Amy D. Canute Rev. Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Revocable Trust of which reporting person and his wife are trustee."}],"balance_after":14486,"source":{"system":"sec-edgar","filing":"0001209191-06-010178","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919106010178/doc5.xml","form_type":"5"}},{"id":267426,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2006-02-14T17:07:43.000Z","date":"2005-05-23","kind":"gift","acquired":true,"shares":2074,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Amy D. Canute Rev. Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Revocable Trust of which reporting person and his wife are trustee."}],"balance_after":15810,"source":{"system":"sec-edgar","filing":"0001209191-06-010178","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919106010178/doc5.xml","form_type":"5"}},{"id":267425,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2006-02-14T17:07:43.000Z","date":"2005-05-06","kind":"gift","acquired":true,"shares":1879,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Amy D. Canute Rev. Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Revocable Trust of which reporting person and his wife are trustee."}],"balance_after":13736,"source":{"system":"sec-edgar","filing":"0001209191-06-010178","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919106010178/doc5.xml","form_type":"5"}},{"id":267424,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2006-02-14T17:07:43.000Z","date":"2005-08-29","kind":"gift","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-06-010178","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919106010178/doc5.xml","form_type":"5"}},{"id":267423,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2006-02-14T17:07:43.000Z","date":"2005-05-23","kind":"gift","acquired":false,"shares":2074,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-06-010178","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919106010178/doc5.xml","form_type":"5"}},{"id":267422,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2006-02-14T17:07:43.000Z","date":"2005-05-06","kind":"gift","acquired":false,"shares":1879,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001209191-06-010178","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919106010178/doc5.xml","form_type":"5"}},{"id":268930,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2006-01-24T20:00:20.000Z","date":"2006-01-20","kind":"grant","acquired":true,"shares":11680,"price":57.04,"value":666227.2,"ownership":{"direct":true},"balance_after":11680,"source":{"system":"sec-edgar","filing":"0001209191-06-004693","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919106004693/doc4.xml","form_type":"4"}},{"id":275737,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Employee stock option 10/96 (right to buy)","published_at":"2005-08-17T20:22:34.000Z","date":"2005-08-16","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":34.595,"exercise_date":"1999-10-21","expiration_date":"2006-10-20","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-05-043153","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105043153/doc4.xml","form_type":"4"}},{"id":275736,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Employee stock option 10/95 (right to buy)","published_at":"2005-08-17T20:22:34.000Z","date":"2005-08-16","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":23.4075,"exercise_date":"1998-10-16","expiration_date":"2005-10-15","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-05-043153","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105043153/doc4.xml","form_type":"4"}},{"id":275735,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2005-08-17T20:22:34.000Z","date":"2005-08-10","kind":"gift","acquired":true,"shares":2091,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Amy D. Canute Rev. Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Reporting person disclaims beneficial ownership of these shares."}],"balance_after":13948,"source":{"system":"sec-edgar","filing":"0001209191-05-043153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105043153/doc4.xml","form_type":"4"}},{"id":275734,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2005-08-17T20:22:34.000Z","date":"2005-08-16","kind":"exercise","acquired":true,"shares":2000,"price":34.5,"value":69000.0,"ownership":{"direct":true},"balance_after":6753,"source":{"system":"sec-edgar","filing":"0001209191-05-043153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105043153/doc4.xml","form_type":"4"}},{"id":275733,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2005-08-17T20:22:34.000Z","date":"2005-08-16","kind":"exercise","acquired":true,"shares":4000,"price":23.4,"value":93600.0,"ownership":{"direct":true},"balance_after":4753,"source":{"system":"sec-edgar","filing":"0001209191-05-043153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105043153/doc4.xml","form_type":"4"}},{"id":275732,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2005-08-17T20:22:34.000Z","date":"2005-08-15","kind":"sale","acquired":false,"shares":400,"price":53.31,"value":21324.0,"ownership":{"direct":true},"balance_after":753,"source":{"system":"sec-edgar","filing":"0001209191-05-043153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105043153/doc4.xml","form_type":"4"}},{"id":275731,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2005-08-17T20:22:34.000Z","date":"2005-08-15","kind":"sale","acquired":false,"shares":2800,"price":53.3,"value":149240.0,"ownership":{"direct":true},"balance_after":1153,"source":{"system":"sec-edgar","filing":"0001209191-05-043153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105043153/doc4.xml","form_type":"4"}},{"id":275730,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2005-08-17T20:22:34.000Z","date":"2005-08-10","kind":"gift","acquired":false,"shares":2091,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3953,"source":{"system":"sec-edgar","filing":"0001209191-05-043153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105043153/doc4.xml","form_type":"4"}},{"id":276247,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Employee stock option 10/96 (right to buy)","published_at":"2005-08-09T19:30:37.000Z","date":"2005-08-03","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amendment is being filed to correct the number of beneficially owned shares reported as acquired on the original Form 4 when the shares were actually disposed of."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The amendment is being filed to correct the number of beneficially owned shares reported as acquired on the original Form 4 when the shares were actually disposed of."}],"balance_after":2000,"derivative":{"exercise_price":34.595,"exercise_date":"1999-10-21","expiration_date":"2006-10-20","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-05-041590","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105041590/doc4a.xml","form_type":"4/A","original_submission_date":"2005-08-05"}},{"id":276246,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Employee stock option 10/95 (right to buy)","published_at":"2005-08-09T19:30:37.000Z","date":"2005-08-03","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amendment is being filed to correct the number of beneficially owned shares reported as acquired on the original Form 4 when the shares were actually disposed of."}],"balance_after":4000,"derivative":{"exercise_price":23.4075,"exercise_date":"1998-10-16","expiration_date":"2005-10-15","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-05-041590","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105041590/doc4a.xml","form_type":"4/A","original_submission_date":"2005-08-05"}},{"id":276334,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Employee stock option 10/96 (right to buy)","published_at":"2005-08-05T18:38:42.000Z","date":"2005-08-03","kind":"exercise","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6000,"derivative":{"exercise_price":34.595,"exercise_date":"1999-10-21","expiration_date":"2006-10-20","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-05-041035","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105041035/doc4.xml","form_type":"4"}},{"id":276333,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Employee stock option 10/95 (right to buy)","published_at":"2005-08-05T18:38:42.000Z","date":"2005-08-03","kind":"exercise","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12000,"derivative":{"exercise_price":23.4075,"exercise_date":"1998-10-16","expiration_date":"2005-10-15","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-05-041035","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105041035/doc4.xml","form_type":"4"}},{"id":276332,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2005-08-05T18:38:42.000Z","date":"2005-08-03","kind":"tax_withholding","acquired":false,"shares":2418,"price":54.88,"value":132699.84,"ownership":{"direct":true},"balance_after":6044,"source":{"system":"sec-edgar","filing":"0001209191-05-041035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105041035/doc4.xml","form_type":"4"}},{"id":276331,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2005-08-05T18:38:42.000Z","date":"2005-08-03","kind":"tax_withholding","acquired":false,"shares":1491,"price":54.88,"value":81826.08,"ownership":{"direct":true},"balance_after":8462,"source":{"system":"sec-edgar","filing":"0001209191-05-041035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105041035/doc4.xml","form_type":"4"}},{"id":276330,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2005-08-05T18:38:42.000Z","date":"2005-08-03","kind":"exercise","acquired":true,"shares":4000,"price":23.41,"value":93640.0,"ownership":{"direct":true},"balance_after":9953,"source":{"system":"sec-edgar","filing":"0001209191-05-041035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105041035/doc4.xml","form_type":"4"}},{"id":276329,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2005-08-05T18:38:42.000Z","date":"2005-08-03","kind":"exercise","acquired":true,"shares":2000,"price":34.6,"value":69200.0,"ownership":{"direct":true},"balance_after":5953,"source":{"system":"sec-edgar","filing":"0001209191-05-041035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105041035/doc4.xml","form_type":"4"}},{"id":277597,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2005-07-21T20:59:12.000Z","date":"2005-05-23","kind":"tax_withholding","acquired":false,"shares":926,"price":58.9,"value":54541.4,"ownership":{"direct":true},"balance_after":3953,"source":{"system":"sec-edgar","filing":"0001209191-05-038077","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105038077/doc4.xml","form_type":"4"}},{"id":281802,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Employee stock option (right to buy)","published_at":"2005-02-15T21:37:17.000Z","date":"2005-02-11","kind":"grant","acquired":true,"shares":46154,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":46154,"derivative":{"exercise_price":55.65,"exercise_date":"2008-02-11","expiration_date":"2015-02-10","underlying":"Common Stock","underlying_shares":46154},"source":{"system":"sec-edgar","filing":"0000059478-05-000055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947805000055/doc4.xml","form_type":"4"}},{"id":283201,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":13586,"kind":"person","name":"Canute Scott A","position":1,"cik":"0001303416","reported_name":"Canute Scott A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mfg. Operations"}}],"security":"Common Stock","published_at":"2005-01-18T20:04:47.000Z","date":"2005-01-14","kind":"grant","acquired":true,"shares":1879,"price":56.79,"value":106708.41,"ownership":{"direct":true},"balance_after":4879,"source":{"system":"sec-edgar","filing":"0000059478-05-000023","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947805000023/doc4.xml","form_type":"4"}}]}